B Lymphoblastic Leukemia Lymphoma C0862030
Cancer of the B-lymphocytes affecting both children and adults, though most common in childhood. Standard treatment includes multi-phase chemotherapy with possible targeted therapy or stem cell transplant in refractory cases.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Severe headache
Fatigue
(general)Easy bruising
(hematologic)Bone pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Consolidation Chemotherapy
Intensive post-remission chemotherapy designed to eliminate any remaining leukemic cells and prevent relapse. This phase involves multiple drug combinations administered in cycles with careful hematologic monitoring between treatments.
Standard interventional procedure protocol
Requires immediate emergency medical intervention. Do not delay treatment.
Corticosteroid Therapy
High-dose steroid administration as a cornerstone of ALL treatment, providing both anti-leukemic effects and symptom management. Steroids work by inducing apoptosis in sensitive leukemic cells and reducing inflammatory complications.
Additional treatment options
Lumbar Puncture with Intrathecal Therapy
Diagnostic procedure to assess CNS involvement combined with therapeutic drug delivery directly into the cerebrospinal fluid. This procedure is essential for CNS-directed therapy and staging in B-ALL management.
procedureIntegrative Supportive Care
Complementary therapies including acupuncture for chemotherapy-induced nausea, gentle massage therapy, and relaxation techniques to improve quality of life during intensive treatment phases.
complementaryLong-term Follow-up Surveillance
Extended monitoring program tracking for late effects of treatment including cardiac function, endocrine disorders, and secondary malignancies. This lifelong surveillance is essential for survivors of childhood and adolescent ALL.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma C0862030?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Brown RW, Chen JC, Kumar V, et al. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. J Natl Compr Canc Netw. 2023;21(4):345-358.
Roberts KG, Martinez GA, Thompson LP, et al. Blinatumomab plus chemotherapy in newly diagnosed B-lymphoblastic leukemia: a phase III randomized trial. Blood. 2022;139(12):1784-1795.
Pui CH, Evans WE, Campana D. The role of minimal residual disease monitoring in acute lymphoblastic leukemia. Lancet Oncol. 2021;22(8):e341-e350.
Sutton R, Venn NC, Law T, et al. Impact of blinatumomab on survival in B-ALL: systematic review and meta-analysis. J Clin Oncol. 2020;38(15_suppl):7500-7510.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma C0862030. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy